Comparison of postoperative nausea and vomiting between remimazolam and sevoflurane in middle ear surgery
Not Applicable
- Conditions
- Diseases of the ear and mastoid process
- Registration Number
- KCT0006975
- Lead Sponsor
- Dong-A University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
American Society of Anesthesiologists physical status classification I, II, or III.
- Patients aged 20 to 80 who agreed to participate in the study.
- Patients undergoing surgery in Dong-A university hospital.
Exclusion Criteria
- Patients with hypersensitivity to Remimazolam and other benzodiazepines.
- Emergency operation.
- Patients with morbid obesity. (BMI >35)
- Patients in the intensive care unit or previously scheduled to be transferred to the intensive care unit after surgery.
- Maternity or lactating club.
- Patients who are unable to communicate and have cognitive impairment.
- Patients whose bispectral index is not adjusted to between 40 and 60 even after 30 minutes from the start of surgery.
- Patient's refusal.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postoperative nausea and vomiting within 12 hours after surgery
- Secondary Outcome Measures
Name Time Method